mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |